Home › NDC Lookup › RxCUI directory › RxCUI 856460

24 HR propranolol hydrochloride 120 MG Extended Release Oral Capsule — RxCUI 856460

RxNorm drug concept · Semantic clinical drug
RxCUI 856460 Semantic clinical drug · SCD ● Current RxNorm concept 34 FDA products 64 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856460
Official name24 HR propranolol hydrochloride 120 MG Extended Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspropranolol HCl 120 MG 24HR Extended Release Oral Capsule
FDA products mapped34
Package NDCs mapped64
Reported Medicaid activity (SDUD)439,696 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Propranolol (Infantile Hemangioma): what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The IV form is reserved for serious heart rhythm emergencies where a fast response is needed — situations where there's no time to wait for a pill to be absorbed. It's given in a h...
  • Why is my child receiving propranolol through an IV instead of a pill?
  • The main ones to know about are a very slow heart rate, a significant drop in blood pressure, and difficulty breathing or wheezing — especially in anyone with asthma or lung diseas...
  • What are the most important side effects to watch for while someone is on this IV medication?
📖 Read our full Propranolol (Infantile Hemangioma) guide →

🕸️ Concept Web — How 24 HR propranolol hydrochloride 120 MG Extended... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR propranolol hydrochloride 120 MG Extended Release Oral Capsule RxCUI 856460

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Propranolol 8787
    • Propranolol hydrochloride 82084
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Inderal 151890
    • InnoPran 856468
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Propranolol Extended Release Oral Capsule 373652
    • Propranolol hydrochloride Extended Release Oral Capsule 2645407
    • Propranolol Oral Product 1162936
    • Propranolol Pill 1162937
    • Propranolol hydrochloride Oral Product 2663563
    • Propranolol hydrochloride Pill 2663688
    • Propranolol Extended Release Oral Capsule [Inderal] 491323
    • Propranolol Extended Release Oral Capsule [InnoPran] 856470
    • +9 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Propranolol hydrochloride 120 MG SCDC · 856392
  • Propranolol Extended Release Oral Capsule SCDF · 373652
  • Propranolol hydrochloride Extended Release Oral Capsule SCDFP · 2645407
  • Propranolol Oral Product SCDG · 1162936
  • Propranolol Pill SCDG · 1162937
  • Propranolol hydrochloride Oral Product SCDGP · 2663563
  • Propranolol hydrochloride Pill SCDGP · 2663688

Brand-Name Concepts

📦 FDA Products & Package NDCs

34 products · 64 package NDCs
64 package NDCs map to RxCUI 856460 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00228-2778-11 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2778-11) Propranolol Hydrochloride Actavis Pharma, Inc. 2007-08-10
00228-2779-11 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2779-11) Propranolol Hydrochloride Actavis Pharma, Inc. 2007-08-10
00228-2780-11 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2780-11) Propranolol Hydrochloride Actavis Pharma, Inc. 2007-08-10
00228-2781-11 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-2781-11) Propranolol Hydrochloride Actavis Pharma, Inc. 2007-08-10
00527-4116-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4116-37) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4116-41 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4116-41) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4117-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4117-37) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4117-41 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4117-41) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4118-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4118-37) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4118-41 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4118-41) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4119-37 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4119-37) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
00527-4119-41 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0527-4119-41) Propranolol Hydrochloride Lannett Company, Inc. 2020-01-06
42291-0522-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-522-01) propranolol hydrochloride AvKARE 2017-05-16
42291-0522-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-522-10) propranolol hydrochloride AvKARE 2017-07-31
42291-0523-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-523-01) propranolol hydrochloride AvKARE 2017-05-16
42291-0523-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-523-10) propranolol hydrochloride AvKARE 2017-07-31
42291-0524-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-524-01) propranolol hydrochloride AvKARE 2017-05-16
42291-0524-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-524-10) propranolol hydrochloride AvKARE 2017-07-31
42291-0525-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-525-01) propranolol hydrochloride AvKARE 2017-05-16
42291-0525-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-525-10) propranolol hydrochloride AvKARE 2017-07-31
51991-0817-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-817-01) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0817-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-817-05) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0818-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-818-01) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0818-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-818-05) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0819-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-819-01) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0819-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-819-05) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0820-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-820-01) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
51991-0820-05 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51991-820-05) propranolol hydrochloride Breckenridge Pharmaceutical, Inc. 2013-03-11
62559-0520-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-520-01) INDERAL LA ANI Pharmaceuticals, Inc. 2017-04-28
62559-0520-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-520-30) INDERAL LA ANI Pharmaceuticals, Inc. 2024-08-05
62559-0521-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-521-01) INDERAL LA ANI Pharmaceuticals, Inc. 2017-04-28
62559-0521-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-521-30) INDERAL LA ANI Pharmaceuticals, Inc. 2024-08-05
62559-0522-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-522-01) INDERAL LA ANI Pharmaceuticals, Inc. 2017-04-28
62559-0522-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-522-30) INDERAL LA ANI Pharmaceuticals, Inc. 2024-08-05
62559-0523-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-523-01) INDERAL LA ANI Pharmaceuticals, Inc. 2017-04-28
62559-0523-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-523-30) INDERAL LA ANI Pharmaceuticals, Inc. 2024-08-05
62559-0530-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-530-01) Propranolol Hydrochloride ER ANI Pharmaceuticals, Inc. 2017-12-21
62559-0531-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-531-01) Propranolol Hydrochloride ER ANI Pharmaceuticals, Inc. 2017-12-21
62559-0532-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-532-01) Propranolol Hydrochloride ER ANI Pharmaceuticals, Inc. 2017-12-21
62559-0533-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-533-01) Propranolol Hydrochloride ER ANI Pharmaceuticals, Inc. 2017-12-21
62559-0590-14 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-590-14) InnoPran XL ANI Pharmaceuticals, Inc. 2021-09-01
62559-0590-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-590-30) InnoPran XL ANI Pharmaceuticals, Inc. 2018-02-22
62559-0590-77 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-590-77) InnoPran XL ANI Pharmaceuticals, Inc. 2018-02-22
62559-0591-14 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-591-14) InnoPran XL ANI Pharmaceuticals, Inc. 2021-09-01
62559-0591-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-591-30) InnoPran XL ANI Pharmaceuticals, Inc. 2018-02-22
62559-0591-77 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-591-77) InnoPran XL ANI Pharmaceuticals, Inc. 2018-02-22
62559-0600-14 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-600-14) Inderal XL ANI Pharmaceuticals, Inc. 2021-09-01
62559-0600-30 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-600-30) Inderal XL ANI Pharmaceuticals, Inc. 2018-02-22
62559-0600-77 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-600-77) Inderal XL ANI Pharmaceuticals, Inc. 2018-02-22
62559-0601-14 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-601-14) Inderal XL ANI Pharmaceuticals, Inc. 2021-09-01
Observed labelers: ANI Pharmaceuticals, Inc. (24) · AvKARE (8) · Breckenridge Pharmaceutical, Inc. (8) · Bryant Ranch Prepack (8) · Lannett Company, Inc. (8) · Actavis Pharma, Inc. (4) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.